Daniel Heinrich

8.1k total citations
94 papers, 1.7k citations indexed

About

Daniel Heinrich is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Daniel Heinrich has authored 94 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Radiology, Nuclear Medicine and Imaging, 43 papers in Pulmonary and Respiratory Medicine and 38 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Daniel Heinrich's work include Radiopharmaceutical Chemistry and Applications (40 papers), Hormonal Regulation and Hypertension (37 papers) and Prostate Cancer Treatment and Research (36 papers). Daniel Heinrich is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (40 papers), Hormonal Regulation and Hypertension (37 papers) and Prostate Cancer Treatment and Research (36 papers). Daniel Heinrich collaborates with scholars based in Germany, Norway and United States. Daniel Heinrich's co-authors include Joe M. O’Sullivan, Sten Nilsson, Oliver Sartor, Martín Reincke, Christian Adolf, Chris Parker, Felix Beuschlein, Joan Carles, Fred Saad and Silke Gillessen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Daniel Heinrich

88 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Heinrich Germany 23 949 719 552 521 518 94 1.7k
Gerald H. Sokol United States 12 2.1k 2.2× 263 0.4× 224 0.4× 310 0.6× 160 0.3× 38 2.5k
Takashi Imamoto Japan 24 911 1.0× 94 0.1× 564 1.0× 343 0.7× 255 0.5× 64 1.5k
Mary Anne Fallon United States 12 1.2k 1.3× 272 0.4× 518 0.9× 114 0.2× 1.2k 2.2× 15 2.0k
Jun‐ichi Teranishi Japan 18 286 0.3× 269 0.4× 124 0.2× 221 0.4× 194 0.4× 73 988
Jacques Planas Spain 22 1.2k 1.3× 120 0.2× 418 0.8× 165 0.3× 330 0.6× 137 1.6k
Carmela Romano Italy 20 307 0.3× 332 0.5× 60 0.1× 199 0.4× 449 0.9× 76 1.5k
Masatoshi Okazaki Japan 19 272 0.3× 169 0.2× 82 0.1× 716 1.4× 253 0.5× 55 1.8k
Ali Ziada United States 19 586 0.6× 99 0.1× 153 0.3× 296 0.6× 128 0.2× 48 1.4k
Gianluca Bottoni Italy 17 194 0.2× 293 0.4× 171 0.3× 196 0.4× 135 0.3× 54 806
A. Bockisch Germany 21 182 0.2× 643 0.9× 843 1.5× 400 0.8× 205 0.4× 98 1.5k

Countries citing papers authored by Daniel Heinrich

Since Specialization
Citations

This map shows the geographic impact of Daniel Heinrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Heinrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Heinrich more than expected).

Fields of papers citing papers by Daniel Heinrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Heinrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Heinrich. The network helps show where Daniel Heinrich may publish in the future.

Co-authorship network of co-authors of Daniel Heinrich

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Heinrich. A scholar is included among the top collaborators of Daniel Heinrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Heinrich. Daniel Heinrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heinrich, Daniel, Martin Bidlingmaier, Felix Beuschlein, et al.. (2024). Impact of confirmatory test results on subtype classification and biochemical outcome following unilateral adrenalectomy in patients with primary aldosteronism. Frontiers in Endocrinology. 15. 1495959–1495959. 2 indexed citations
2.
Heinrich, Daniel, Ulrich Dischinger, Nicole Reisch, et al.. (2024). Mild autonomous cortisol secretion leads to reduced volumetric BMD at lumbar spine in patients with primary aldosteronism. Frontiers in Endocrinology. 15. 1521680–1521680.
3.
Adolf, Christian, Holger Schneider, Lisa Mueller, et al.. (2023). Postoperative ACTH-stimulated aldosterone predicts biochemical outcome in primary aldosteronism. European Journal of Endocrinology. 189(6). 611–618. 3 indexed citations
4.
5.
Mittermeier, Andreas, Balthasar Schachtner, Vanessa F. Schmidt, et al.. (2023). Integration of clinical parameters and CT-based radiomics improves machine learning assisted subtyping of primary hyperaldosteronism. Frontiers in Endocrinology. 14. 1244342–1244342. 4 indexed citations
6.
Ree, Anne Hansen, Vigdis Nygaard, Hege G. Russnes, et al.. (2019). Responsiveness to PD-1 Blockade in End-Stage Colon Cancer with Gene Locus 9p24.1 Copy-Number Gain. Cancer Immunology Research. 7(5). 701–706. 5 indexed citations
7.
Braun, Leah, Christian Lottspeich, Daniel Heinrich, et al.. (2019). Scaffolding clinical reasoning of medical students with virtual patients: effects on diagnostic accuracy, efficiency, and errors. Diagnosis. 6(2). 137–149. 19 indexed citations
8.
Decmann, Ábel, Gábor Nyírő, Irina Bancos, et al.. (2019). Circulating miRNA Expression Profiling in Primary Aldosteronism. Frontiers in Endocrinology. 10. 739–739. 24 indexed citations
9.
Heidenreich, Axel, Silke Gillessen, Daniel Heinrich, et al.. (2019). Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program. BMC Cancer. 19(1). 12–12. 33 indexed citations
10.
Sartor, Oliver, Daniel Heinrich, Neil Mariados, et al.. (2019). Re‐treatment with radium‐223: 2‐year follow‐up from an international, open‐label, phase 1/2 study in patients with castration‐resistant prostate cancer and bone metastases. The Prostate. 79(14). 1683–1691. 16 indexed citations
11.
O’Sullivan, Joe M., Joan Carles, Richard Cathomas, et al.. (2019). Radium-223 Within the Evolving Treatment Options for Metastatic Castration-resistant Prostate Cancer: Recommendations from a European Expert Working Group. European Urology Oncology. 3(4). 455–463. 25 indexed citations
12.
Heinrich, Daniel, Amanda Tufman, Jochen Schopohl, et al.. (2018). IGF-1-based screening reveals a low prevalence of acromegaly in patients with obstructive sleep apnea. Endocrine. 60(2). 317–322. 7 indexed citations
13.
Sartor, Oliver, Daniel Heinrich, Neil Mariados, et al.. (2017). Re-treatment with radium-223: first experience from an international, open-label, phase I/II study in patients with castration-resistant prostate cancer and bone metastases. Annals of Oncology. 28(10). 2464–2471. 21 indexed citations
14.
15.
16.
Sartor, Oliver, Daniel Heinrich, Neil Mariados, et al.. (2016). Radium-223 re-treatment from an international, prospective, open-label study in patients with castration-resistant prostate cancer and bone metastases. Annals of Oncology. 27. vi255–vi255. 1 indexed citations
17.
Saad, Fred, Axel Heidenreich, Daniel Heinrich, et al.. (2016). Radium-223 with concomitant bone-targeting agents in metastatic castration-resistant prostate cancer (CRPC) patients treated in an international early access program (EAP). Annals of Oncology. 27. vi254–vi254. 1 indexed citations
18.
19.
Paganelli, Giovanni, Giuseppe Procopio, Enrico Cortesi, et al.. (2016). Analysis of overall survival by number of radium-223 injections received in an international expanded access program (iEAP). Annals of Oncology. 27. iv35–iv35. 5 indexed citations
20.
Parker, Chris, Daniel Heinrich, David Bottomley, et al.. (2013). Effects of radium-223 dichloride (Ra-223) on health-related quality of life (QOL) outcomes in the phase 3 ALSYMPCA study in patients with castration-resistant prostate cancer (CRPC) and bone metastases. European Journal of Cancer. 49. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerald H. Sokol Breakdown of academic impact, for papers by Takashi Imamoto Breakdown of academic impact, for papers by Mary Anne Fallon Breakdown of academic impact, for papers by Jun‐ichi Teranishi Breakdown of academic impact, for papers by Jacques Planas Breakdown of academic impact, for papers by Carmela Romano Breakdown of academic impact, for papers by Masatoshi Okazaki Breakdown of academic impact, for papers by Ali Ziada Breakdown of academic impact, for papers by Gianluca Bottoni Breakdown of academic impact, for papers by A. Bockisch
Rankless by CCL
2026